RenovoRx, Inc. (RNXT): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

35.33M
Year ended 2025-12-31
+57.5%
3-year compound annual growth
2022-12-31: 9.05M2023-12-31: 10.29M2024-12-31: 22.27M2025-12-31: 35.33M35.33M
2022-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3135.33M+58.6%2026-03-30, From 2025-01-01
2024-12-3122.27M+116.4%2026-03-30, From 2024-01-01
2023-12-3110.29M+13.7%2025-04-01, From 2023-01-01
2022-12-319.05Mn/a2024-04-01, From 2022-01-01